Susquehanna Fundamental Investments’s Cardlytics CDLX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,463	Closed	-$26.6K	–	765
2025 Q1	$26.6K	Sell	1,463 -7,458	-84%	-$213K	﹤0.01%	1050
2024 Q4	$331K	Buy	+8,921	New	+$341K	﹤0.01%	924
2024 Q2	$180K	Sell	2,194 -960	-30%	-$104K	﹤0.01%	858
2024 Q1	$457K	Buy	3,154 +384	+14%	+$32.4K	0.02%	482
2023 Q4	$255K	Sell	2,770 -1,762	-39%	-$179K	0.26%	42
2023 Q3	$748K	Hold	4,532	–	–	0.05%	225
2023 Q2	$286K	Sell	4,532 -1,488	-25%	-$90.1K	0.01%	527
2023 Q1	$204K	Hold	6,020	–	–	﹤0.01%	862
2022 Q4	$348K	Buy	+6,020	New	+$372K	0.01%	954

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Susquehanna Fundamental Investments's CDLX Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 1,463 shares — an estimated $26.6K sold.

Susquehanna Fundamental Investments first reported a position in CDLX in Q4 2022 and held it in 9 quarters. The position peaked at $748K in Q3 2023. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

Susquehanna Fundamental Investments reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 1,463 Cardlytics shares in Q2 2025, an estimated $26.6K.
Susquehanna Fundamental Investments first reported a position in Cardlytics in Q4 2022 and held it in 9 quarters.
Susquehanna Fundamental Investments's Cardlytics position peaked at $748K in Q3 2023.
89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.